GB9225860D0 - Novel treatment - Google Patents

Novel treatment

Info

Publication number
GB9225860D0
GB9225860D0 GB929225860A GB9225860A GB9225860D0 GB 9225860 D0 GB9225860 D0 GB 9225860D0 GB 929225860 A GB929225860 A GB 929225860A GB 9225860 A GB9225860 A GB 9225860A GB 9225860 D0 GB9225860 D0 GB 9225860D0
Authority
GB
United Kingdom
Prior art keywords
novel treatment
novel
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB929225860A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Priority to GB929225860A priority Critical patent/GB9225860D0/en
Publication of GB9225860D0 publication Critical patent/GB9225860D0/en
Priority to EP94902046A priority patent/EP0673248A1/en
Priority to JP6513936A priority patent/JPH08504432A/en
Priority to PCT/GB1993/002514 priority patent/WO1994013292A1/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
GB929225860A 1992-12-11 1992-12-11 Novel treatment Pending GB9225860D0 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
GB929225860A GB9225860D0 (en) 1992-12-11 1992-12-11 Novel treatment
EP94902046A EP0673248A1 (en) 1992-12-11 1993-12-08 Potassium channel activators for use in therapy
JP6513936A JPH08504432A (en) 1992-12-11 1993-12-08 Potassium channel activator useful in therapy
PCT/GB1993/002514 WO1994013292A1 (en) 1992-12-11 1993-12-08 Potassium channel activators for use in therapy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929225860A GB9225860D0 (en) 1992-12-11 1992-12-11 Novel treatment

Publications (1)

Publication Number Publication Date
GB9225860D0 true GB9225860D0 (en) 1993-02-03

Family

ID=10726441

Family Applications (1)

Application Number Title Priority Date Filing Date
GB929225860A Pending GB9225860D0 (en) 1992-12-11 1992-12-11 Novel treatment

Country Status (4)

Country Link
EP (1) EP0673248A1 (en)
JP (1) JPH08504432A (en)
GB (1) GB9225860D0 (en)
WO (1) WO1994013292A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6245893B1 (en) 1994-12-17 2001-06-12 Smithkline Beecham P.L.C. Receptor that binds anti-convulsant compounds
GB9425502D0 (en) * 1994-12-17 1995-02-15 Smithkline Beecham Plc Novel receptor
DE19707656A1 (en) * 1997-02-26 1998-08-27 Hoechst Ag Sulphonamide-substituted fused 7-ring compounds, processes for their preparation, their use as medicaments or diagnostic agents and pharmaceutical preparations containing them
US6333349B1 (en) 1997-02-26 2001-12-25 Aventis Pharma Deutschland Gmbh Sulfonamide-substituted fused 7-membered ring compounds, their use as a medicament, and pharmaceutical preparations comprising them
GB9909792D0 (en) * 1998-12-04 1999-06-23 Cambridge Bioclinical Limited Potassium channel activators and their use
HUE034911T2 (en) 2009-07-27 2018-03-28 Gilead Sciences Inc Fused heterocyclic compounds as ion channel modulators
CN103096977B (en) 2010-07-02 2017-02-15 吉利德科学公司 Fused heterocyclic compounds as ion channel modulators
CN102141055B (en) * 2011-02-25 2013-12-04 南京高精船用设备有限公司 Hydraulic-control throttling hydraulic valve and application thereof
US9115096B2 (en) 2011-05-10 2015-08-25 Gilead Sciences, Inc. Fused heterocyclic compounds as ion channel modulators
UY34171A (en) 2011-07-01 2013-01-31 Gilead Sciences Inc FUSIONED HETEROCYCLIC COMPOUNDS AS IONIC CHANNEL MODULATORS
NO3175985T3 (en) 2011-07-01 2018-04-28

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8414987D0 (en) * 1984-06-12 1984-07-18 Beecham Group Plc Active compounds
DK691488A (en) * 1987-12-14 1989-06-15 Beecham Group Plc UNKNOWN RELATIONSHIPS
GB8730051D0 (en) * 1987-12-23 1988-02-03 Beecham Group Plc Novel compounds
GB8812765D0 (en) * 1988-05-28 1988-06-29 Beecham Group Plc Novel compounds
NZ230711A (en) * 1988-09-23 1990-10-26 Ortho Pharma Corp Substituted thienopyrans as antihypertensive agents
FR2639227A1 (en) * 1988-11-23 1990-05-25 Sanofi Sa USE OF CHROMANE DERIVATIVES FOR THE TREATMENT OF DEPRESSIVE STATES
GB8828679D0 (en) * 1988-12-08 1989-01-11 Beecham Group Plc Novel treatment
EP0376524B1 (en) * 1988-12-13 1995-03-29 Beecham Group Plc Benzopyran and related compounds
TW224941B (en) * 1989-11-08 1994-06-11 Yamanouchi Pharma Co Ltd
WO1991009031A1 (en) * 1989-12-11 1991-06-27 Beecham Group Plc Trifluoromethyl substituted compounds and a pharmaceutical composition
US5401848A (en) * 1990-11-26 1995-03-28 E. R. Squibb & Sons, Inc. Indane and quinoline derivatives
NZ240933A (en) * 1990-12-21 1993-05-26 Ortho Pharma Corp Preparing enantiomerically pure thienopyran derivatives
GB9112721D0 (en) * 1991-06-13 1991-07-31 Smithkline Beecham Plc Novel treatment

Also Published As

Publication number Publication date
EP0673248A1 (en) 1995-09-27
WO1994013292A1 (en) 1994-06-23
JPH08504432A (en) 1996-05-14

Similar Documents

Publication Publication Date Title
GB9215633D0 (en) Novel treatment
GB9208339D0 (en) Treatment composition
GB9127150D0 (en) Novel treatment
GB9226860D0 (en) Novel treatment
GB9211148D0 (en) Novel treatment
GB9203039D0 (en) Treatment
GB9225860D0 (en) Novel treatment
GB9226957D0 (en) Novel treatment
GB9226958D0 (en) Produktionsaktieselskab) novel treatment
GB9308802D0 (en) Treatment
AP9300527A0 (en) Novel treatment
GB9203637D0 (en) Novel treatment
GB9225859D0 (en) Novel treatment
AP9200456A0 (en) Novel treatment
GB9225948D0 (en) Novel treatment
GB9225858D0 (en) Novel treatment
GB9214209D0 (en) Novel treatment
GB9225861D0 (en) Novel treatment
GB9207219D0 (en) Novel treatment
GB9225964D0 (en) Novel treatment
GB9225963D0 (en) Novel treatment
GB9225957D0 (en) Novel treatment
GB9225961D0 (en) Novel treatment
GB9225959D0 (en) Novel treatment
GB9225956D0 (en) Novel treatment